Rich Yang

So if you're going to have that information in real-time feedback using color schemas, that is glucose range monitoring.

It works even if you don't have a phone.

So one of the things that we really had to work around is for people that don't use insulin, what do they do with a number?

Because let's just say, for example, you're high.

Well, there's no acute medication decisions this patient population would be doing because they're not taking insulin.

Correct.

So how do you inspire positive behavior change, drive cognitive restructuring without a number?

And so we really wanted to simplify the use of time and range information and make it simple for everybody to understand the immediate impact of the foods that you may be eating, right?

In your activity levels, in your change in sleep patterns, right?

So, we did that, and because it's semi-quantitative information, it is considered glucose range monitoring.

So, it's very different from the ICGM category where you could actually have interoperability with insulin delivery devices.

Our sensors are not intended for insulin dosing, and so it's not intended to be integrated with insulin pumps or insulin pens, but it's really a standalone device.

Great question.

BioLink Shine is a prescription product today.

And we intended for it to be a prescription product because we believe there will be an opportunity for some form of reimbursement.

Now, while people that are not using insulin may not need sensors full time all the time.

So the big question is, could we provide enough benefit on a cost neutral basis to what finger sticks cost to payers and health systems and large self insurers such that there could be some form of partial reimbursement for periodic use?

And so we will be aggressively looking at this question to see if we can generate a

outcome studies and cost-benefit studies so that some form of partial reimbursement for periodic use could be made available.

This is one of the most important tools for people with diabetes that are not on insulin.